Anti-Infectives Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
MiddleBrook Pharmaceuticals, Inc.
MiddleBrook Pharmaceuticals Announces $20 Maximum Copay Program for MOXATAG®
July 27th, 2009
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), announced that it has implemented a $20 maximum copay program for MOXATAG (amoxicillin extended-release) Tablets, 775 mg. The program is designed to keep a patient's net out-of-pocket copay expense for a MOXATAG prescription at $20 or less. Today, MiddleBrook's 300 field force representatives and district managers will begin supplying physicians with MOXATAG $20 maximum copay voucher cards to distribute to patients with MOXATAG prescriptions. Patients can redeem the voucher at the point-of-sale in conjunction with having a MOXATAG prescription filled. "In this tough economy, we recognized the need to improve MOXATAG's...
Source: Anti-Infectives Week (2009-07-27)
|
